|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Amoxicilline trihydraat - Kalium clavulanaat 
|
|
125/31,25 mg Suspension. Recent available EU registation dossier
Offer available for: licensing Pharmaceutical form and dosage: 125/31,25 mg
Type:
- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
Therapeutic target:
- Infectious Diseases
Action: Antibiotics - systemic (anti-infectives) |
|
|
Full Description:
Amoxicilline trihydraat - Kalium clavulanaat 125/31,25 mg Suspension dossier:
-Newly registered and readily available for licensing
-Stability: 25°C: 24 months + continued, 40°C: 6 months
Availability and Market information:
Status: Registration
Registration info: MA to be obtained soon
Registration in several countries possible on request
BE available
Market information
Other Market Info:
Patent Information:
Name: Augmentin
Patent info: Expired
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.
|
Add
Company
Subscribe
Search
Contact
